4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-24-010722
Chief Financial Officer gave up 4,082 shares (to pay taxes)
- Chief Financial Officer acquired 9,956 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tsuchimoto Kim R Chief Financial Officer | 2024-03-31 | Option exercise | +9,956 | 54,552 | D | ||
| Tsuchimoto Kim R Chief Financial Officer | 2024-03-31 | Shares withheld for taxes | −4,082 | $0.68 | $2,780 | 50,470 | D |
| Derivatives | |||||||
| Tsuchimoto Kim R Chief Financial Officer | 2024-03-31 | Option exercise · Restricted Stock Units | −9,956 | 84,369 | D | ||
Loading xslF345X05/rdgdoc.xml…